202 related articles for article (PubMed ID: 36439177)
1. Spatial architecture of regulatory T-cells correlates with disease progression in patients with nasopharyngeal cancer.
Zhou F; Shayan G; Sun S; Huang X; Chen X; Wang K; Qu Y; Wu R; Zhang Y; Liu Q; Zhang J; Luo J; Shi X; Liu Y; Liang B; Li YX; Wang J; Yi J
Front Immunol; 2022; 13():1015283. PubMed ID: 36439177
[TBL] [Abstract][Full Text] [Related]
2. Intratumoral regulatory T cells alone or in combination with cytotoxic T cells predict prognosis of hepatocellular carcinoma after resection.
Chen KJ; Zhou L; Xie HY; Ahmed TE; Feng XW; Zheng SS
Med Oncol; 2012 Sep; 29(3):1817-26. PubMed ID: 21678026
[TBL] [Abstract][Full Text] [Related]
3. Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection.
Gao Q; Qiu SJ; Fan J; Zhou J; Wang XY; Xiao YS; Xu Y; Li YW; Tang ZY
J Clin Oncol; 2007 Jun; 25(18):2586-93. PubMed ID: 17577038
[TBL] [Abstract][Full Text] [Related]
4. Prognostic role of tumor infiltrating lymphocytes in EBV positive and EBV negative nasopharyngeal carcinoma.
Ooft ML; van Ipenburg JA; Braunius WW; Zuur CI; Koljenović S; Willems SM
Oral Oncol; 2017 Aug; 71():16-25. PubMed ID: 28688685
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Value of Tumor Infiltrating Lymphocytes in Nasopharyngeal Carcinoma Patients: Meta-Analysis.
Berele BA; Cai Y; Yang G
Technol Cancer Res Treat; 2021; 20():15330338211034265. PubMed ID: 34323154
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of tumor-infiltrating lymphocytes and macrophages in nasopharyngeal carcinoma: a systematic review and meta-analysis.
Liu W; Chen G; Zhang C; Liao X; Xie J; Liang T; Liao W; Song L; Zhang X
Eur Arch Otorhinolaryngol; 2022 Jan; 279(1):25-35. PubMed ID: 34027599
[TBL] [Abstract][Full Text] [Related]
7. Detailed analysis of inflammatory cell infiltration and the prognostic impact on nasopharyngeal carcinoma.
Lu J; Chen XM; Huang HR; Zhao FP; Wang F; Liu X; Li XP
Head Neck; 2018 Jun; 40(6):1245-1253. PubMed ID: 29493822
[TBL] [Abstract][Full Text] [Related]
8. Higher intratumoral infiltrated Foxp3+ Treg numbers and Foxp3+/CD8+ ratio are associated with adverse prognosis in resectable gastric cancer.
Shen Z; Zhou S; Wang Y; Li RL; Zhong C; Liang C; Sun Y
J Cancer Res Clin Oncol; 2010 Oct; 136(10):1585-95. PubMed ID: 20221835
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of tumor-infiltrating lymphocytes in nondisseminated nasopharyngeal carcinoma: A large-scale cohort study.
Wang YQ; Chen YP; Zhang Y; Jiang W; Liu N; Yun JP; Sun Y; He QM; Tang XR; Wen X; Yang XJ; Zhang PP; Zhang J; Lei Y; Li YQ; Ma J
Int J Cancer; 2018 Jun; 142(12):2558-2566. PubMed ID: 29377121
[TBL] [Abstract][Full Text] [Related]
10. The predictive and prognostic value of Foxp3+/CD25+ regulatory T cells and PD-L1 expression in triple negative breast cancer.
Zhang L; Wang XI; Ding J; Sun Q; Zhang S
Ann Diagn Pathol; 2019 Jun; 40():143-151. PubMed ID: 31096176
[TBL] [Abstract][Full Text] [Related]
11. Increase in tumour-infiltrating lymphocytes with regulatory T cell immunophenotypes and reduced zeta-chain expression in nasopharyngeal carcinoma patients.
Yip WK; Abdullah MA; Yusoff SM; Seow HF
Clin Exp Immunol; 2009 Mar; 155(3):412-22. PubMed ID: 19220831
[TBL] [Abstract][Full Text] [Related]
12. Stromal PD-L1-Positive Regulatory T cells and PD-1-Positive CD8-Positive T cells Define the Response of Different Subsets of Non-Small Cell Lung Cancer to PD-1/PD-L1 Blockade Immunotherapy.
Wu SP; Liao RQ; Tu HY; Wang WJ; Dong ZY; Huang SM; Guo WB; Gou LY; Sun HW; Zhang Q; Xie Z; Yan LX; Su J; Yang JJ; Zhong WZ; Zhang XC; Wu YL
J Thorac Oncol; 2018 Apr; 13(4):521-532. PubMed ID: 29269008
[TBL] [Abstract][Full Text] [Related]
13. Lymphocyte activating gene 3 protein expression in nasopharyngeal carcinoma is correlated with programmed cell death-1 and programmed cell death ligand-1, tumor-infiltrating lymphocytes.
Luo F; Cao J; Lu F; Zeng K; Ma W; Huang Y; Zhang L; Zhao H
Cancer Cell Int; 2021 Aug; 21(1):458. PubMed ID: 34454491
[TBL] [Abstract][Full Text] [Related]
14. Prognostic role of tumour-associated macrophages and regulatory T cells in EBV-positive and EBV-negative nasopharyngeal carcinoma.
Ooft ML; van Ipenburg JA; Sanders ME; Kranendonk M; Hofland I; de Bree R; Koljenović S; Willems SM
J Clin Pathol; 2018 Mar; 71(3):267-274. PubMed ID: 28877959
[TBL] [Abstract][Full Text] [Related]
15. A Standardized Evaluation Method for FOXP3+ Tregs and CD8+ T-cells in Breast Carcinoma: Association With Breast Carcinoma Subtypes, Stage and Prognosis.
Papaioannou E; Sakellakis M; Melachrinou M; Tzoracoleftherakis E; Kalofonos H; Kourea E
Anticancer Res; 2019 Mar; 39(3):1217-1232. PubMed ID: 30842152
[TBL] [Abstract][Full Text] [Related]
16. The impact of tumor-infiltrating lymphocytes on tumor features and pathological characteristics in breast cancer patients: the role of cytotoxic T lymphocytes and regulatory T cells.
Fares M; Ayoub NM; Marji R; Al Bashir SM; Al-Shari OM
Eur Rev Med Pharmacol Sci; 2022 Jun; 26(12):4207-4219. PubMed ID: 35776019
[TBL] [Abstract][Full Text] [Related]
17. CD8+ Tumor-Infiltrating Lymphocyte Abundance Is a Positive Prognostic Indicator in Nasopharyngeal Cancer.
Shi W; Fijardo M; Bruce JP; Su J; Xu W; Bell R; Bissey PA; Hui ABY; Waldron J; Pugh TJ; Yip KW; Liu FF
Clin Cancer Res; 2022 Dec; 28(23):5202-5210. PubMed ID: 36129469
[TBL] [Abstract][Full Text] [Related]
18. Interplay between glucocorticoids and tumor-infiltrating lymphocytes on the prognosis of adrenocortical carcinoma.
Landwehr LS; Altieri B; Schreiner J; Sbiera I; Weigand I; Kroiss M; Fassnacht M; Sbiera S
J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32474412
[TBL] [Abstract][Full Text] [Related]
19. Tumor-infiltrating FoxP3+ Tregs and CD8+ T cells affect the prognosis of hepatocellular carcinoma patients.
Huang Y; Wang FM; Wang T; Wang YJ; Zhu ZY; Gao YT; Du Z
Digestion; 2012; 86(4):329-37. PubMed ID: 23207161
[TBL] [Abstract][Full Text] [Related]
20. CD3+T-lymphocyte infiltration is an independent prognostic factor for advanced nasopharyngeal carcinoma.
Al-Rajhi N; Soudy H; Ahmed SA; Elhassan T; Mohammed SF; Khoja HA; Ghebeh H
BMC Cancer; 2020 Mar; 20(1):240. PubMed ID: 32199452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
